Divergent trajectories in fatal drug harms across high-income settings: a comparative synthesis of public surveillance indicators, 2015–23
Journal of Public Health · 2026
DOI: 10.1093/pubmed/fdag042 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Public Health, 2026. Verfasst von Ovie Martin Albert und 1 weiteren Autor:innen. Beteiligte Einrichtung: VODP, Addiction and Mental Health, Centennial Centre for Mental Health and Brain Injury, AB Health Services/Recovery Alberta, PO Box 1000, Ponoka, Al…. Hauptthemen laut MEDLINE: Developed Countries, Drug Overdose, Substance-Related Disorders, Public Health Surveillance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Fatal drug-related harms have risen across high-income countries over the past decade, yet national surveillance systems differ substantially in case definitions, reporting timeliness, and indicator coverage. These differences make it difficult to determine whether observed cross-national differences reflect epidemiological divergence or heterogeneous measurement.
Methods
To address this, we compared public surveillance indicators of fatal drug-related harm across the USA, Canada, England and Wales, and European countries reporting to the European Union Drugs Agency (2015–23), using three domains: drug-supply toxicity, surveillance latency, and treatment-system integration.
Results
Fatal drug-harm indicators suggested divergent trajectories: the USA experienced rapid mortality escalation through 2022 followed by a modest decline, while England and Wales reported continued increases in registration-based deaths. In Canada, deaths involving three or more substances increased from 20% in 2018 to 42% in 2023, with opioid–stimulant combinations accounting for ~60% of deaths by 2023. European estimates remained provisional due to incomplete national reporting. Differences between occurrence-based and registration-based surveillance influenced the apparent timing of trends. Continuity of opioid agonist treatment across incarceration transitions emerged as a measurable treatment-integration signal.
Conclusions
High-income settings appear to follow distinct fatal drug-harm trajectories shaped by drug-supply toxicity, surveillance architecture, and treatment-system integration. A structured multi-domain framework can help distinguish epidemiological divergence from variation caused by measurement and reporting. It can also guide improvements in timely surveillance, treatment-continuity monitoring, and cross-jurisdictional learning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VODP, Addiction and Mental Health, Centennial Centre for Mental Health and Brain Injury, AB Health Services/Recovery Alberta, PO Box 1000, Ponoka, Alberta, T4J 1R8, Canada.
- Department of Family Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada.
- Department of Family Medicine, University of Saskatchewan, West Winds Primary Health Centre, 3311 Fairlight Drive, Saskatoon, Saskatchewan, S7M 3Y5, Canada.
- St. Joseph's Hospital, 1175 Nicholson Road, Estevan, Saskatchewan, Saskatchewan, S4A 2V6, Canada.
Zitieren
APA
Albert, O. M., & Arthur, A. (2026). Divergent trajectories in fatal drug harms across high-income settings: a comparative synthesis of public surveillance indicators, 2015–23. Journal of Public Health. https://doi.org/10.1093/pubmed/fdag042
Vancouver
Albert OM, Arthur A. Divergent trajectories in fatal drug harms across high-income settings: a comparative synthesis of public surveillance indicators, 2015–23. Journal of Public Health. 2026. doi:10.1093/pubmed/fdag042
BibTeX
@article{Albert2026,
author = {Albert, Ovie Martin and Arthur, Alexander},
title = {Divergent trajectories in fatal drug harms across high-income settings: a comparative synthesis of public surveillance indicators, 2015–23},
journal = {Journal of Public Health},
year = {2026},
doi = {10.1093/pubmed/fdag042}
}
EUVIMED